Last updated: August 28, 2023
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Urinary Incontinence
Enuresis
Urinary Tract Infections
Treatment
medical treatment(desmopressin acetate)
infrared (gallium aluminum arsenide laser)
Clinical Study ID
NCT05399173
P.T.REC/012/003689
Ages 10-18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adolescent females have to meet the following criteria in order to participate in thisstudy:
- Suffering from Monosymptomatic nocturnal enuresis.
- Their ages will range from 10-18 years.
- Resistance to medical treatment (desmopressin acetate)
Exclusion
Exclusion Criteria:
- Adolescent Females with the following criteria will be excluded from this study:
- Psychological or neurological disorders or other organic disorders.
- Any chronic diseases.
- Spinal cord abnormalities associated neurogenic bladder.
- Evidence of urinary tract infection.
- Ectopic ureter In addition, chronic constipation or encopresis.
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: medical treatment(desmopressin acetate)
Phase:
Study Start date:
June 02, 2022
Estimated Completion Date:
September 08, 2023
Study Description
Connect with a study center
Faculty of physical therapy
Giza,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.